Cargando…
Interventional pulmonology use of cell-free DNA assay for metastatic non–small cell lung cancer: the UC Davis experience
BACKGROUND: Interventional pulmonologists (IPs) are often the first specialist to see patients with suspected metastatic non–small cell lung cancer (mNSCLC). Consequently, they are potentially ideally positioned to expedite the identification of actionable molecular mutations by ordering blood-based...
Autores principales: | Phan, Chinh, Jespersen, Forrest, Weipert, Caroline, Li, Tianhong, Yoneda, Ken Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647290/ https://www.ncbi.nlm.nih.gov/pubmed/36346075 http://dx.doi.org/10.1177/17534666221135324 |
Ejemplares similares
-
UC Davis - MSRI Conference on Mathematical Physics : Festschrift Schwarz (Albert)
Publicado: (2004) -
Meeting Report and Abstracts of the 2005 UC Davis Transgenic Animal Research Conference V
por: Murray, James D.
Publicado: (2006) -
Building an institutional K awardee program at UC Davis through utilization of CTSA resources
por: Guo, Betty P., et al.
Publicado: (2021) -
Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC
por: Ma, Weijie, et al.
Publicado: (2021) -
Pulmonology
por: Martínez-Fernández, Tanya, et al.
Publicado: (2019)